Status:
COMPLETED
My Scrivener® - Measuring Effectiveness and Dose Response in Children
Lead Sponsor:
Obslap Research LLC
Conditions:
Asperger's Syndrome
Dyslexia
Eligibility:
All Genders
5-19 years
Phase:
PHASE1
PHASE2
Brief Summary
This study will assess whether a computer haptic peripheral device programmed to provide repetitive motion training is as effective as the same repetitive motion training provided by a human being.
Detailed Description
This study builds on a large body of neurological research that uses robot-guided repetitive motion training to induce neuroplasticity and improvements in upper extremity motor skills in adults and ch...
Eligibility Criteria
Inclusion
- Meet the following base prerequisites for writing: orientation to written language; eye-hand coordination, single handed utensil or tool manipulation (BAMF score \>= 6), recognize all letters of the alphabet (unless the child has dyslexia).
- Children have illegible printing for their grade, or legible printing but a speed less than the norms for their grade and sex.
- Be able to grasp a pen.
- Be able to speak and understand English.
- Be able to follow instructions.
- Be able to devote at least 20 minutes to the assigned tasks (short breaks will be allowed).
- Be enrolled in school at grade K or above.
- A score lower than 80% on the Print Tool™ or the Cursive Tool.
Exclusion
- Unable to pass the informed assent screener.
- Unwilling to sign or mark the informed assent documents.
- Uncontrolled spasticity.
- A BAMF score lower than 6 (includes severe paralysis of the upper extremity).
- Cerebral palsy other than hemiplegia cerebral palsy
- Severe autism or intellectual disabilities that prevent productive interactions with the investigator
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT00919906
Start Date
April 1 2009
End Date
September 1 2010
Last Update
October 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Susan Palsbo
Eugene, Oregon, United States, 97405